Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation
Attila Szabo, Kevin S. O’Connell, Thor Ueland, Mashhood A. Sheikh, Ingrid Agartz, Dimitrios Andreou, Pål Aukrust, Birgitte Boye, Erlend Bøen, Ole Kristian Drange, Torbjørn Elvsåshagen, John Abel Engh, Sigrun Hope, Margrethe Collier Høegh, Inge Joa, Erik Johnsen, Rune Andreas Kroken, Trine Vik Lagerberg, Tove Lekva, Ulrik Fredrik Malt, Ingrid Melle, Gunnar Morken, Terje Nærland, Vidar Martin Steen, Kjetil Sørensen, Kirsten Wedervang-Resell, Melissa Auten Weibell, Lars T. Westlye, Nils Eiel Steen, Ole Andreassen, Srdjan Djurovic
doi: https://doi.org/10.1101/2021.05.28.21258013
Attila Szabo
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
2Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
Kevin S. O’Connell
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
Thor Ueland
3Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
4Institute of Clinical Medicine, University of Oslo, Oslo, Norway
5K.G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway
Mashhood A. Sheikh
3Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
Ingrid Agartz
6Norwegian Centre for Mental Disorders Research, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
7Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden
8Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
Dimitrios Andreou
6Norwegian Centre for Mental Disorders Research, NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
7Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden
Pål Aukrust
3Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
4Institute of Clinical Medicine, University of Oslo, Oslo, Norway
9Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway
Birgitte Boye
10Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
11Psychosomatic and Consultation-Liason Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
Erlend Bøen
11Psychosomatic and Consultation-Liason Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
Ole Kristian Drange
12Department of Mental Health, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
13Department of Østmarka, Division of Mental Health, St. Olavs University Hospital, Trondheim, Norway
14Department of Psychiatry, St Olav University Hospital, Trondheim, Norway
Torbjørn Elvsåshagen
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
4Institute of Clinical Medicine, University of Oslo, Oslo, Norway
15Department of Neurology, Oslo University Hospital, Oslo, Norway
John Abel Engh
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
2Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
Sigrun Hope
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
16Department of Neuro Habilitation, Oslo University Hospital Ullevål, Oslo, Norway
Margrethe Collier Høegh
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
Inge Joa
17TIPS, Centre for Clinical Research in Psychosis, Stavanger University Hospital, Stavanger, Norway
18Network for Medical Sciences, Faculty of Health, University of Stavanger, Stavanger, Norway
Erik Johnsen
19Division of Psychiatry, Haukeland University Hospital, Bergen, Norway
20NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway
21Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway
Rune Andreas Kroken
19Division of Psychiatry, Haukeland University Hospital, Bergen, Norway
20NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway
21Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway
Trine Vik Lagerberg
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
Tove Lekva
3Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
Ulrik Fredrik Malt
4Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Ingrid Melle
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
4Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Gunnar Morken
12Department of Mental Health, Norwegian University of Science and Technology, NTNU, Trondheim, Norway
14Department of Psychiatry, St Olav University Hospital, Trondheim, Norway
Terje Nærland
4Institute of Clinical Medicine, University of Oslo, Oslo, Norway
22K.G. Jebsen Center for Neurodevelopmental Disorders, Oslo, Norway
23Department of Rare Disorders and Disabilities, Oslo University Hospital, Oslo, Norway
Vidar Martin Steen
20NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway
21Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway
Kjetil Sørensen
24Department of Psychiatry, St. Olav’s University Hospital, Trondheim, Norway
Kirsten Wedervang-Resell
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
Melissa Auten Weibell
17TIPS, Centre for Clinical Research in Psychosis, Stavanger University Hospital, Stavanger, Norway
18Network for Medical Sciences, Faculty of Health, University of Stavanger, Stavanger, Norway
Lars T. Westlye
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
22K.G. Jebsen Center for Neurodevelopmental Disorders, Oslo, Norway
25Department of Psychology, University of Oslo, Oslo, Norway
Nils Eiel Steen
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
Ole Andreassen
1Norwegian Centre for Mental Disorders Research, NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
Srdjan Djurovic
2Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
20NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway
Article usage
Posted May 31, 2021.
Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation
Attila Szabo, Kevin S. O’Connell, Thor Ueland, Mashhood A. Sheikh, Ingrid Agartz, Dimitrios Andreou, Pål Aukrust, Birgitte Boye, Erlend Bøen, Ole Kristian Drange, Torbjørn Elvsåshagen, John Abel Engh, Sigrun Hope, Margrethe Collier Høegh, Inge Joa, Erik Johnsen, Rune Andreas Kroken, Trine Vik Lagerberg, Tove Lekva, Ulrik Fredrik Malt, Ingrid Melle, Gunnar Morken, Terje Nærland, Vidar Martin Steen, Kjetil Sørensen, Kirsten Wedervang-Resell, Melissa Auten Weibell, Lars T. Westlye, Nils Eiel Steen, Ole Andreassen, Srdjan Djurovic
medRxiv 2021.05.28.21258013; doi: https://doi.org/10.1101/2021.05.28.21258013
Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation
Attila Szabo, Kevin S. O’Connell, Thor Ueland, Mashhood A. Sheikh, Ingrid Agartz, Dimitrios Andreou, Pål Aukrust, Birgitte Boye, Erlend Bøen, Ole Kristian Drange, Torbjørn Elvsåshagen, John Abel Engh, Sigrun Hope, Margrethe Collier Høegh, Inge Joa, Erik Johnsen, Rune Andreas Kroken, Trine Vik Lagerberg, Tove Lekva, Ulrik Fredrik Malt, Ingrid Melle, Gunnar Morken, Terje Nærland, Vidar Martin Steen, Kjetil Sørensen, Kirsten Wedervang-Resell, Melissa Auten Weibell, Lars T. Westlye, Nils Eiel Steen, Ole Andreassen, Srdjan Djurovic
medRxiv 2021.05.28.21258013; doi: https://doi.org/10.1101/2021.05.28.21258013
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)